TigerOak Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-26,902
Closed -$652K 121
2025
Q2
$652K Sell
26,902
-1,593
-6% -$37.2K 0.22% 62
2025
Q1
$722K Sell
28,495
-3,036
-10% -$79.4K 0.28% 54
2024
Q4
$837K Buy
+31,531
New +$855K 0.31% 48

Other funds holding PFE

TigerOak Management's PFE Position: Q3 2025 in Review

TigerOak Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 26,902 shares — an estimated $652K sold.

TigerOak Management first reported a position in PFE in Q4 2024 and held it in 3 quarters. The position peaked at $837K in Q4 2024. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • TigerOak Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • TigerOak Management sold 26,902 Pfizer shares in Q3 2025, an estimated $652K.
  • TigerOak Management first reported a position in Pfizer in Q4 2024 and held it in 3 quarters.
  • TigerOak Management's Pfizer position peaked at $837K in Q4 2024.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on TigerOak Management's 13F filing for Q3 2025, filed 10 Nov 2025.